Skip to main content
Applied and Environmental Microbiology logoLink to Applied and Environmental Microbiology
. 2026 Mar 31;92(4):e02108-25. doi: 10.1128/aem.02108-25

Genomic landscape of blaNDM-1- and blaOXA-181-carrying Citrobacter portucalensis sequence type 151 strains from hospital wastewater in Ghana

Frederick Ofosu Appiah 1,2, Yusuke Ota 1, Jennifer Seyram Amedior 3, Emmanuel Darko 3, Mitsunori Yoshida 4, Masato Suzuki 5, Yoshihiko Hoshino 4, Toshihiko Suzuki 6, Tomoko Ishino 2, Anthony Ablordey 3, Ryoichi Saito 1,✉
Editor: Satoshi Ishii7
PMCID: PMC13101484  PMID: 41914734

ABSTRACT

Carbapenemases represent one of the major driving forces of antimicrobial resistance (AMR), which has been recognized as a significant public health concern. Additionally, hospital wastewater (HWW) serves as a critical hotspot for the spread of antibiotic-resistant bacteria (ARB) and genes (ARGs). In this study, we report the isolation of difficult-to-identify Citrobacter portucalensis strains that harbor blaNDM-1 and blaOXA-181 from hospital wastewater in Ghana. Wastewater was collected at the Effia Nkwanta Regional Hospital of Ghana, and carbapenemase producers were screened using selective media and multiplex PCR. Antimicrobial susceptibility testing, conjugation, and whole-genome sequencing were performed on the isolates. Two strains (HW7-CARBA and HW8-CARBA) isolated from hospital wastewater were initially identified as Citrobacter freundii but confirmed as C. portucalensis by whole-genome sequencing. These strains were assigned to ST151 and harbored ARGs consistent with their multidrug-resistant phenotype. The blaNDM-1 gene was located on the ~45.0 kb IncX3 plasmid (pHW7-CARBA-NDM-1), which was transferable in the conjugation assay, while the blaOXA-181 gene was bracketed with IS26 on the ~90.0 kb nonconjugative ColKP3 plasmid (pHW8-CARBA-OXA-181). pHW7-CARBA-NDM-1 showed close phylogenetic similarity to a plasmid from China, whereas pHW8-CARBA-OXA-181 was closely related to the blaOXA-181 plasmid derived from Escherichia coli isolated from the stool sample of a pediatric patient with diarrhea in Ghana. Consequently, HWW serves as a hotspot for ARB and ARGs, increasing the risk of AMR proliferation. Addressing these challenges is essential for protecting public health and contributing to global efforts to preserve antibiotic efficacy. Recommendations include implementing comprehensive AMR-focused regulatory frameworks.

IMPORTANCE

The operations of hospitals generate wastewater that serves as a critical hotspot for antibiotic-resistant bacteria and genes. Many hospitals discharge untreated wastewater, leading to the widespread occurrence of carbapenemase-producing Enterobacteriaceae, which presents significant challenges for environmental health. The significance of our research lies in determining the genomic landscape of antibiotic-resistant genes in the less-explored Citrobacter portucalensis isolated from hospital wastewater. This research will contribute to preventing the spread of environmental resistance, implementing antimicrobial resistance monitoring standards, and protecting vulnerable populations from exposure.

KEYWORDS: Citrobacter portucalensis, hospital wastewater, bla NDM-1 , bla OXA-181 , IncX3, ColKP3

INTRODUCTION

The emergence and prevalence of antimicrobial resistance (AMR) are increasingly recognized as significant public health concerns on a global scale (1). Bacterial AMR is reported to result in approximately 1.14 million deaths annually, with the majority occurring in low- and middle-income countries (LMICs) (2). In contrast, the United States and Europe record approximately 23,000 and 25,000 deaths each year, respectively (3). Unfortunately, the environmental contribution to this pressing issue is often underestimated, despite its potential as a key driver (4). Currently, there are no documented figures that accurately reflect the environmental contribution to the overall AMR health crisis.

Hospitals are vital for advancing medical science and supporting healthcare systems (5), but they also face significant challenges regarding environmental health due to the wastewater they produce (6, 7). Hospital wastewater (HWW) is particularly concerning as it contains antibiotic-resistant bacteria (ARB) and genes (ARGs), toxic chemicals, antibiotic residues, and pathogens (6, 7). The discharge of wastewater without proper treatment is particularly common in LMICs, leading to the dissemination of ARGs and ARB (8–10). Alarmingly, some farmers use untreated HWW to irrigate crops and vegetables meant for human consumption, thereby directly exposing individuals to ARGs and ARB (11). Moreover, community wastewater is relatively less toxic than HWW due to lower contaminant levels (12, 13), positioning hospitals as critical hotspots for AMR and environmental pollution.

Furthermore, carbapenemases are the most significant enzymes that neutralize antibiotics, especially carbapenems (14). The majority of acquired carbapenemases belong to three of the four known classes of β-lactamases: Ambler class A enzymes, such as Klebsiella pneumoniae carbapenemase (KPC) types; Ambler class B enzymes, or metallo-β-lactamases, including Verona integron-encoded metallo-β-lactamase (VIM), imipenemase (IMP), and New Delhi metallo-β-lactamase (NDM) types; and Ambler class D enzymes, or oxacillinases, such as OXA-23, OXA-48, and OXA-181 types (15, 16). NDM is a type of metallo-β-lactamases that can break down the majority of β-lactam antibiotics, which are typically considered first-line drugs to treat infections (17, 18). The emergence of NDM-producing bacteria significantly limits clinical therapeutic options, complicating medical interventions for infectious diseases caused by these pathogens (19, 20). NDM-1 was first described in 2008 in India, and since that time, Enterobacteriaceae possessing NDM-1 have been isolated from patients in various countries, including the USA, Canada, the United Kingdom, Europe, Australia, Oman, Japan, Singapore, and Africa (19–21). In Ghana, multiple reports of blaNDM-1 have been documented (22–24).

Since the discovery of Ambler class D enzymes OXA-48, a total of 48 variants have been identified (https://www.ncbi.nlm.nih.gov/pathogens/refgene/#oxa-48, accessed on 20 April 2025), with OXA-181 being the second-most common (25). The spread of OXA-181 producers has been documented in France (26), the Netherlands (27), and India (28). Additionally, the dissemination of the blaOXA-181 gene has been reported in Africa (29–31), with specific occurrences noted in Ghana (32–34).

Finally, Citrobacter portucalensis is challenging to identify and is often underestimated (35); however, carbapenemase-producing strains have been documented. The first report of blaNDM-1 producing C. portucalensis was documented in China, marking the first clinical case of blaNDM-1-carrying C. portucalensis (35). This was subsequently followed by several reports, including a drug-resistant clinical strain harboring both blaKPC-2 and blaNDM-1 (36), as well as an extensively drug-resistant clinical C. portucalensis that exhibited the rare coexistence of blaSFO-1, blaKPC-2, and blaNDM-1 genes (37).

We hereby report, for the first time, the isolation of two multidrug-resistant C. portucalensis strains harboring blaNDM-1 and blaOXA-181 from hospital wastewater in Ghana.

RESULTS

Bacterial identification, antimicrobial susceptibility testing, and conjugal transfer of blaNDM-1 and blaOXA-181

Two strains (HW7-CARBA and HW8-CARBA) were obtained from hospital wastewater and initially identified as C. freundii by 16S rRNA gene sequencing but confirmed as C. portucalensis with an average nucleotide identity (ANI) score 98.51% using strain A60 (GCF_002042885.1) as the reference. HW7-CARBA and HW8-CARBA exhibited resistance or intermediate resistance to all classes of β-lactam antibiotics, levofloxacin, and gentamicin, with the exception of HW8-CARBA, which demonstrated sensitivity to imipenem (Table 1). Additionally, both strains were sensitive to amikacin, tigecycline, and colistin (Table 1). The HW7-CARBA and HW8-CARBA strains also tested positive for modified carbapenemase inactivation (mCIM) and harbored the blaNDM-1 and blaOXA-181 genes, respectively, and the ETEST analysis also confirmed the resistance of both strains to meropenem. Conjugation analysis revealed that HW7-CARBA successfully transferred the blaNDM-1gene to the recipient strain Escherichia coli J53, while the blaOXA-181 gene from HW8-CARBA was not transferred. PCR testing confirmed the presence of blaNDM-1 (Fig. S1), and 16S rRNA sequencing identified the transconjugant strain as E. coli. The transconjugant Tc-NDM-1 also conferred resistance to β-lactam antibiotics, with the exception of aztreonam, and demonstrated sensitivity to amikacin, gentamicin, tigecycline, and colistin (Table 1). The oriTfinder results indicated that the conjugative region of pHW7-CARBA-NDM-1 contained all four modules: the origin of transfer site (oriT), relaxase gene, gene encoding type IV coupling protein (T4CP), and gene cluster for the bacterial type IV secretion system (T4SS). In contrast, pHW8-CARBA-OXA-181 contained only the relaxase gene. Both strains harbored resistant genes for heavy metals such as mercury (merA, merD, merE, merT, and merR) and arsenic (arsA, arsB, arsC, arsD, and arsR) (Tables S4 and S5).

TABLE 1.

Antimicrobial susceptibility profiles of the two isolates and a transconjuganta

Antimicrobial agent MIC (μg/mL) for:
HW7-CARBA Tc-NDM-1 HW8-CARBA
Ampicillin >16 (R) >16 (R) >16 (R)
Ampicillin/sulbactam >16/8 (R) >16/8 (R) >16/8 (R)
Cefazolin >16 (R) >16 (R) >16 (R)
Ceftazidime >8 (R) >8 (R) >8 (R)
Cefpodoxime >4 (R) >4 (R) >4 (R)
Ceftriaxone >32 (R) >32 (R) >32 (R)
Cefepime >16 (R) >16 (R) >16 (R)
Levofloxacin >1 (R) >1 (R) >1 (R)
Imipenem 2 (l) 2 (l) 1 (S)
Meropenem 4 (R) 2 (I) 2 (I)
Amikacin ≤8 (S) ≤8 (S) ≤16 (S)
Gentamicin >8 (R) 2 (S) >8 (R)
Aztreonam >8 (R) 2 (S) >8 (R)
Tigecycline ≤1 (S) 0.25 (S) ≤1 (S)
Colistin ≤1 (S) ≤1 (S) ≤1 (S)
a

S, susceptible; R, resistant; l, intermediate; Tc-NDM-1, transconjugant.

Genomic characterization of HW7-CARBA and HW8-CARBA and phylogeny analysis

The genome of HW7-CARBA comprised a chromosome of 5,012,851 bp and 7 circular plasmids ranging in size from 3,361 bp to 241,933 bp (Table 2). This strain harbored multiple ARGs, including those for β-lactams (blaNDM-1, blaOXA-1, blaCTX-M-15, blaTEM-1B, and blaCMY-124), tetracycline (tet(D)), aminoglycosides (aac(6′)-Ib-cr,), quinolone (qnrS1 and qnrB76), and sulfonamide/dihydrofolate reductase inhibitors (sul1, sul2, and dfrA12) (Table 2). Notably, the blaNDM-1 gene was localized on a 44,962 bp IncX3 plasmid. In comparison, the genome of HW8-CARBA consisted of a chromosome of 5,233,847 bp and 6 circular plasmids ranging from 3,361 bp to 239,022 bp (Table 2). HW8-CARBA also contained ARGs for β-lactams (blaOXA-181, blaOXA-1, blaCTX-M-15, blaTEM-1B, and blaCMY-124), tetracycline (tet(D)), aminoglycosides (aac(6′)-Ib-cr,), quinolone (qnrS1 and qnrB76), and sulfonamide/dihydrofolate reductase inhibitors (sul1, sul2, and dfrA12) (Table 2). The blaOXA-181 gene was found on an 89,673 bp ColKP3-type plasmid.

TABLE 2.

Chromosome and plasmid features of HW7-CARBA and HW8-CARBA

Strain name Chromosome/ plasmid Size (bp) MLST Plasmid incompatibility group Antibiotic resistance gene(s)
HW7-CARBA Chromosome 5,012,851 ST151 –a blaCMY-124, qnrB76
pHW7-CARBA-1 241,933 – blaOXA-1, blaTEM-1B, tet(D), sul1, sul2, dfrA12, aac(3)-lld, aadA2, aac(6’)-lb-cr), mph(A), catB3, cattA2
pHW7-CARBA-2 85,230 IncFII (CF) qnrS1
pHW7-CARBA-3 72,754 repB (R1701) mph(A), blaTEM-1B, blaCTX-M-15 aph(6)-ld, aph(6)-ld, aac(3)-lld, aac(3)-lld)
pHW7-CARBA-4 55,112 – –
pHW7-CARBA-NDM-1 44,962 IncX bla NDM-1
pHW7-CARBA-6 3,482 – –
pHW7-CARBA-7 3,361 – –
HW8-CARBA Chromosome 5,233,847 ST151 – blaCMY-124, blaTEM-1B,blaOXA-1, qnrB76, qnrB1
pHW8-CARBA-1 239,022 – aac(3)-lld, aadA2,aac(6’)-lb-cr, tet(D), sul1, dfrA12, mph(A), catB3, catA2
pHW8-CARBA-2 96,068 IncFII (CF) –
pHW8-CARBA-OXA-181 89,673 ColKP3 aac(3)-lld, aac(3)-lla, aph(6)-ld, aph(6)-ld), blaCTX-M-15, blaTEM-1B, blaOXA-181, mph(A), qnrS1
pHW8-CARBA-4 9,264 IncQ1 sul2
pHW8-CARBA-5 3,482 – –
pHW8-CARBA-6 3,361 – –
a

– indicates the absence of plasmid incompatiblity group or ARGs.

The HW7-CARBA and HW8-CARBA strains were both assigned to sequence type (ST) 151. We investigated their phylogeny within the context of global C. portucalensis collections together with 34 C. portucalensis strains. The metadata for these strains are presented in Fig. 1, with the standard strain of C. portucalensis (CP044098) as the reference strain. The phylogenetic tree was divided into two primary groups, each containing distinct subclades, while the reference strain (CP044098) and an American strain (GCF_016406035) were out-grouped (Fig. 1). The HW7-CARBA and HW8-CARBA strains were classified within the same group, indicating that they shared similar homology; however, they did not exhibit ancestral homology with the standard strain CP044098 (Fig. 1). Furthermore, HW7-CARBA and HW8-CARBA exhibited similar homology to GCF_016406035, a C. portucalensis strain isolated from farm soil near an antimony mine in China in 2019 (Fig. 1). However, the ST of GCF_016406035 was not available.

Fig 1.

Phylogenetic tree of C. portucalensis showing genetic relationships between study strains HW7-CARBA and HW8-CARBA and global isolates with bootstrap values and metadata for collection dates, locations, isolation sources, hosts, and sequence types.

Population distribution of C. portucalensis strains (HW7-CARBA and HW8-CARBA) with 34 C. portucalensis genomes. The phylogenetic tree was generated using the maximum-likelihood approach. Bootstrap analysis was employed to assess the support level (expressed as a percentage) for each cluster of related taxa, indicated by blue dots adjacent to the branches. The scale of sequence divergence is represented by the accompanying bar. The colors used in the tree correspond to various factors, including the collection date, location, source of isolation, host, and ST of the strains. A dash (-) signifies that data are not available. The reference strain (CP044098) is represented in blue, while the strains from our study are shown in red.

We determined the phylogenetic relatedness of the IncX3- blaNDM-1 plasmid from HW7-CARBA (pHW7-CARBA-NDM-1) and 13 other plasmids exhibiting high homology through BLAST analysis. The analysis indicated that pHW7-CARBA-NDM-1 shared a close genetic distance with a blaNDM-1 plasmid (MH286946.1) in E. coli recovered from chicken in China. Additionally, it shared a common lineage with two other blaNDM-1 plasmids (MT621567.1 and OQ230790.1) from China, hosted by E. coli and C. werkmanii, respectively, and recovered from chicken and swine (Fig. 2).

Fig 2.

Phylogenetic tree showing blaNDM-1 and blaNDM-5 plasmid relationships with pHW7-CARBA-NDM-1 highlighted. Bootstrap values range 21-99. Matrix displays geographic distribution, isolation timeline, sources, hosts, and gene presence patterns.

Analysis of the evolutionary relatedness of pHW7-CARBA-NDM-1 (indicated in red) and other blaNDM-1 and blaNDM-5 plasmids. Branch patterns were assessed using 1,000 bootstraps, with symbols and respective values indicated in the legend. The colors depicted correspond to the countries, isolation dates, sources, and host species of the plasmids. The ash color denotes the presence of genes, while the white color signifies their absence.

We conducted a mapping of the contigs of pHW7-CARBA-NDM-1 to the sequences of MH286946.1 and CP029631.1, the latter being a blaNDM-1 plasmid isolated from a hospital in Ghana. The mapping results indicated that our plasmid was identical to MH286946.1 with 100% coverage, while it exhibited no similarity to CP029631.1, with only the blaNDM-1 and ble region showing 100% identity (Fig. 3a). The circular comparison revealed a large, conserved scaffold likely containing numerous conjugative genes, as previously reported (38).

Fig 3.

Circular genomic maps comparing carbapenemase plasmids. pHW7-CARBA-NDM-1 (44962 bp) contains blaNDM-1 gene compared with similar plasmids. pHW8-CARBA-OXA-181 (89673 bp) contains blaOXA-181 gene compared with CP061102.1. Both show sequence identities.

(a) A circular comparison of pHW7-CARBA-NDM-1 and two IncX3-blaNDM-1-containing plasmids (MH286946.1 and CP029631.1). The red, green, and blue colors represent pHW7-CARBA-NDM-1, MH286946.1, and CP029631.1, respectively. (b) A circular comparison of pHW8-CARBA-OXA-181 and CP061102.1, a blaOXA-181-containing plasmid. The red and green colors represent pHW8-CARBA-OXA-181 and CP061102.1, respectively. The homology between the plasmids is shown by the percentage identity in the figure legend.

A detailed examination of the genetic environment of blaNDM-1 on pHW7-CARBA-NDM-1 and MH286946.1 revealed a sequence of open reading frames (ORFs): Tn2-IS300-ISAba125-blaNDM-1-bleMBL-trpF-ISBmu7-IS26. The blaNDM-1 gene was flanked upstream by the insertion sequence ISAba125 and downstream by the bleomycin resistance gene bleMBL, both bordered by Tn2 upstream and IS26 downstream. Conversely, CP029631.1 exhibited a similar sequence but contained a truncated ISAba125 and did not include Tn2 and IS300 (Fig. 4). The large, shaded ash color denotes the similarities in the genetic environments of blaNDM-1 among the plasmids, while the white color signifies the differences (Fig. 4).

Fig 4.

Comparative gene map of blaNDM-1 genetic environment across MH286946.1, pHW7-CARBA-NDM-1, and CP029631.1. Key genes include ISAba125, blaNDM-1, bleMBL, and tnpF shown as directional arrows with shaded regions indicating sequence homology.

Comparison of the genetic environment of blaNDM-1. Arrows depict the genes and sequences upstream and downstream of blaNDM-1in their transcriptional directions, as detected by sequencing. The structure of MH286946.1 was reversed to enable easy comparison. Shaded regions indicate regions that are common to the plasmids.

The evolutionary relatedness analysis revealed that pHW8-CARBA-OXA-181 shares a close genetic relationship with the blaOXA-181 plasmid (CP061102.1) derived from E. coli. Notably, plasmid CP061102.1 was isolated from the stool sample of a pediatric patient with diarrhea in the western region of Ghana (Fig. 5). Furthermore, the CP061102.1 plasmid contained several additional ARGs, including qnrS1, blaTEM-35,sul2, aph(6)-ld, and aph(3”)-lb. In comparison, pHW8-CARBA-OXA-181 harbored a different set of resistance genes, such as blaCTX-M-15, qnrS1, blaTEM-1B, aph(6)-ld, mph(A), aac(3)-lla, and aac(3)-lld (Fig. 5). Additionally, their AMR profiles exhibited phenotypic differences. The phylogenetic analysis involved the blaOXA-181 plasmid (pHW8-CARBA-OXA-181) and 13 other plasmids that exhibited high homology (Fig. 5).

Fig 5.

Phylogenetic tree of pHW8-CARBA-OXA-181 and related blaOXA-181 plasmids with bootstrap values. Matrix shows presence or absence of antibiotic resistance genes. Color coding indicates countries, isolation dates, host species, and sources.

Evolutionary relatedness of pHW8-CARBA-OXA-181 (indicated in red) and other blaOXA-181 plasmids. Branch patterns were assessed using 1,000 bootstraps, with symbols and respective values indicated in the legend. The colors depicted correspond to the countries, isolation dates, sources, and host species of the plasmids. The ash color denotes the presence of genes, while the white color signifies their absence.

The results from the NCBI BLAST analysis indicated that CP061102.1 shared a 99.99% identity and 31% query coverage with pHW8-CARBA-OXA-181. The BRIG comprehensive visual comparison also revealed structural differences between the two plasmids (Fig. 3b). The specific contig section of pHW8-CARBA-OXA-181 that exhibited a perfect 100% identity to CP061102.1 was the blaOXA-181 and qnrS1 (Fig. 3b). Furthermore, a larger portion of the plasmid displayed less than 70% similarity or was completely absent, which could be attributed to deletions or the absence of a scaffold for conjugative genes in pHW8-CARBA-OXA-181 (Fig. 3b).

The comparison of the genetic environment of blaOXA-181 between CP061102.1 and pHW8-CARBA-OXA-181 revealed notable similarities, with some open reading frames differing in presence or absence. The upstream region of blaOXA-181 on pHW8-CARBA-OXA-181 exhibited a sequence of ISEcp1-Tn3-partial-Tn3-IS26, whereas the upstream region of blaOXA-181 on CP061102.1 showed ISEcp1-Tn3-partial-Tn3-IS26-IS26 (Fig. 6). Notably, CP061102.1 harbored two copies of IS26, whereas pHW8-CARBA-OXA-181 possessed only a single copy (Fig. 6). Comparatively, the downstream region of blaOXA-181 on CP061102.1 showcased a sequence of partial ereA-ISKpn19-ISKpn19-ISKpn19-ISKpn19-TnEc2-Tnshfr1-qnrS1-IS3 family-IS26, while pHW8-CARBA-OXA-181 exhibited a sequence of ISKpn19-ISKpn19-ISKpn19-ISKpn19-TnEc2-Tnshfr1-qnrS1-IS2-IS26 (Fig. 6). The immediate downstream region of blaOXA-181 on CP061102.1 harbored a partial ereA and IS3 family, which were absent on pHW8-CARBA-OXA-181, which instead contained IS2 (Fig. 6). However, both plasmids were bracketed by IS26 in the upstream and downstream regions of blaOXA-181 (Fig. 6). The large, shaded ash color denotes the similarities in the genetic environments of blaOXA-181 between the plasmids (Fig. 6).

Fig 6.

Genetic environment of blaOXA-181 showing gene arrangements in two plasmids. Arrows depict genes and their transcriptional directions with shaded regions highlighting sequence similarity between the genetic sequences.

Comparison of the genetic environment of blaOXA-181. Arrows depict the genes and sequences upstream and downstream of blaOXA-181in their transcriptional directions, as detected by sequencing. Shaded regions indicate regions that are common to both plasmids.

DISCUSSION

Citrobacter spp., a genus of gram-negative coliform bacteria within the Enterobacteriaceae family, is found widely in the environment, including soil, water, and wastewater, as well as in the intestines of humans and animals (39). Citrobacter spp. possesses several virulence factors that pathogenic microorganisms use to express their pathogenicity and enhance survival in hosts (40). These factors are closely related to disease and can be elicited during antimicrobial therapy (40). Notable virulence factors include proteolysis, hemolysis, and biofilm formation, which have been previously observed (41). Studies have reported that the use of conventional tests and MALDI-TOF MS for differentiating species of Citrobacter to recognize clinically significant species has been challenging (42–44), thereby highlighting the need for more advanced techniques. Cao et al. reported that among 488 C. freundii genomes downloaded from the GenBank database, 55 were identified as C. portucalensis, with an ANI value greater than 95% (35). Three of these 55 misidentified strains were isolated from Africa. This misidentification corroborates the findings of this study, where our strains were initially identified as C. freundii but later confirmed as C. portucalensis. These strains harbored mercury (Hg)-resistant genes, which have been reported to co-occur with multiple ARGs in bacterial isolates from food animals, fish, and humans due to the ubiquitous presence of Hg in the environment (45–47). Hg has been extensively utilized as an antimicrobial agent in healthcare, agriculture, aquaculture, and industry (48). Therefore, it can be speculated that the survival of C. portucalensis strains against Hg in HWW is based on the Hg-resistant genes they possess. In fact, Li et al. have reported that it is important to reduce Hg concentrations in sewage to minimize the co-selection potential of ARGs in humans and animals (49). The relatively lesser-explored C. portucalensis is gradually gaining attention for its potential contributions to various fields. There have been multiple reports from both clinical and nonclinical samples since strain A60 was identified in 2017 as a novel species of C. portucalensis in Portugal (50). This includes strain MBTC-1222, which was isolated from vegetables in Nigeria in 2018 (51), and strain NR-12, isolated from poultry in Bangladesh in 2019 (52). In 2020, strain RIT669 was documented (53), followed by strain 3839 reported to be isolated from the sputum of a 72-year-old man with polydipsia, polyuria, and cough in China in 2021 (35). In 2022, strain K218 was reported (36), and in 2023, researchers isolated a C. portucalensis strain from an endangered marine animal that succumbed to sepsis (54). In 2024, Guo et al. reported a clinical case of C. portucalensis isolated from the feces of a 56-year-old man with acute diarrhea in China (37), and a strain was also isolated from edible snails in Nigeria (55). This rapidly emerging body of evidence underscores the increasing dissemination of C. portucalensis in both the environment and clinical domains, but there is a relative lack of exploration of this pathogen in Africa. Although reports have been documented in Nigeria, Egypt, and South Africa, there are no available data regarding C. portucalensis in Ghana. Given its diverse adaptability and the clinical underestimation resulting from misidentification, there is a necessity for ongoing molecular surveillance to mitigate the burden of AMR in accordance with the One Health concept.

The 34 C. portucalensis strains involved in the maximum-likelihood phylogenetic analysis were sourced from various locations, with the main collection sites being China, Germany, the United States, and Japan. The C. portucalensis FDAARGOS_617 reference strain (CP044098) out-grouped from the group containing HW7-CARBA and HW8-CARBA strains gives an indication that there is a less relevant evolutionary relationship. Furthermore, GCF_016406035 with an unknown ST type, isolated from farm soil near an antimony mine in China, showed similar homology to the strains in this study, both classified as ST151, a sequence type not yet documented in scientific literature. Numerous reports have described diverse STs of C. portucalensis globally, including ST170 and ST85 from hospitalized patients (36, 37), ST264 from marine animals that succumbed to sepsis (54), and ST881, ST882, ST985, and ST896 from edible snails (55). The classification of our study strains as ST151 may indicate unique characteristics or adaptations. Since this is the first report of ST151 C. portucalensis strains in Ghana, it is challenging to ascertain the possible transmission events and the close relatedness to the Chinese isolate. It can be speculated that the strains isolated from hospital wastewater may have originated from the feces of a patient who has traveled to China, or it is also possible that these strains were introduced directly from China, indicating potential pathways for the spread of these strains. This situation necessitates further research to elucidate the prevalence of this pathogen and its evolutionary routes in Ghana.

Since the initial report of blaNDM-1 -producing C. portucalensis in China (35), there have been several subsequent reports (36, 37, 53). There have been several reports of blaNDM-1-producing Enterobacteriaceae in Ghana and throughout Africa; however, there is a lack of documentation regarding C. portucalensis as a producer of this gene. The blaNDM-1 -producing C. portucalensis from this study also exhibited resistance to the carbapenem, as previously documented (36, 37, 53). An extensively resistant blaNDM-1 -producing strain of C. portucalensis was isolated from the bloody sputum of a 76-year-old male patient diagnosed with type 2 diabetes mellitus (35). Additionally, another study reported the isolation of an extensively resistant blaNDM-1 -producing C. portucalensis from the blood of a 56-year-old male patient admitted to the neurosurgery department. The patient was diagnosed with left thalamic hemorrhage, hydrocephalus, and hypertension (36). Also, the isolation of two multidrug-resistant blaNDM-1 -producing strains of Klebsiella pneumoniae from burn patients in Ghana has been documented (23). These observations underscore the clinical significance of monitoring such resistant strains within hospital settings. The intermediate resistance to meropenem and imipenem exhibited by the transconjugant strain indicates that the blaNDM-1 gene is solely responsible for the hydrolysis of carbapenems. Furthermore, the presence of additional ARGs in strain HW7-CARBA, apart from blaNDM-1, signifies the substantial level of resistance to various antibiotics and underscores the potential health risks associated with this strain. First identified in India in 2007 (36), OXA-181 has since been reported in various countries around the world, including Ghana, affecting humans, animals, and environmental samples (32, 33, 56–58). Despite its classification as a carbapenemase, OXA-181 exhibits instances of low imipenem and meropenem MIC values, which fall within the susceptible range according to the current clinical breakpoints established by the European Committee on Antimicrobial Susceptibility Testing (EUCAST) and Clinical & Laboratory Standards Institute (CLSI). This has been reported in previous studies (59, 60); however, our study strain HW8-CARBA showed resistance to meropenem while being sensitive to imipenem. The varying resistance levels observed in strains carrying blaOXA-181 toward meropenem raise critical questions about the underlying factors contributing to this diversity as some strains show resistance while others remain sensitive (61). This phenomenon raises important questions regarding the clinical management of infections caused by strains with this enzyme. Moreover, the low carbapenemase activity of OXA-48 enzymes may pose challenges in detecting OXA-181 carbapenemases in clinical settings, potentially leading to an underestimation of OXA-181-like-producing Enterobacteriaceae (62). Reports concerning blaOXA-181-producing C. portucalensis are infrequent, with only one documented case in Peru, where it was isolated from the bronchial secretions of a patient (63). Furthermore, the same study also reported the isolation of multidrug-resistant blaOXA-181-producing strains of K. pneumoniae and E. coli from the urine and blood of patients. Additionally, a study conducted in Ghana reported the isolation of two multidrug-resistant blaOXA-181-producing strains of E. coli from the stools of pediatric patients diagnosed with diarrhea (32). Ghana has encountered significant challenges related to AMR, resulting in 5,900 attributable deaths and an additional 25,300 associated deaths (64). The country was ranked 36th globally in terms of age-standardized mortality rates associated with AMR per 100,000 population (64). Donkor et al. reported that the primary determinants of AMR and its dissemination are the weak enforcement and non-adherence to practice standards, policies, and regulations governing the access to and utilization of antimicrobial agents in both human and veterinary medicine (65). Consequently, the isolation of multidrug-resistant C. portucalensis strains from HWW in Ghana informs the evolution of resistance patterns and underscores the necessity for implementing strategies to mitigate the risks posed by these strains. To the best of our knowledge, this is the first report of blaNDM-1- and blaOXA-181-producing C. portucalensis in Ghana.

NDM-1 is often associated with IncX3-type plasmids (66), which consist of plasmids characterized by a narrow host range (67). The analysis presented in Fig. 2 indicated that 14 IncX3-type plasmids were isolated from 5 different host species. Notably, the presence of pHW7-CARBA-NDM-1 in C. portucalensis, which is closely related to MH286946.1 in E. coli, suggests that IncX3-blaNDM-1 plasmids have broadened their host preference. Therefore, understanding the driving forces behind this spread is essential. The genetic environment of blaNDM-1 on pHW7-CARBA-NDM-1 exhibits similarity to MH286946.1, but not to CP029631.1, a blaNDM-1 plasmid that we isolated in our previous research from the urine of a patient at a teaching hospital in Ghana. This observation reflects the diversity in the ORFs surrounding the gene, which may contribute to the resistance mechanisms associated with the blaNDM-1 gene against various antibiotics. The bleMBL gene, which confers resistance to the antitumor glycopeptide bleomycin, was located downstream of the blaNDM-1 gene (68). Previous studies indicate that ISAba125 is typically involved in the formation of Tn125, a complex transposon associated with the plasmid-mediated spread of blaNDM-1 (69, 70). The location of bleMBL and ISAba125 downstream and upstream of blaNDM-1, respectively, has been reported in previous studies (36). Mobile genetic elements (MGEs) such as Tn2 and IS300 have been shown to play a significant role in the dissemination of blaNDM-1, with IS26 being one of the primary contributors (71). Our findings also affirm the transferability of pHW7-CARBA-NDM-1, indicating the potential for strain HW7-CARBA to disseminate the blaNDM-1 gene among other Enterobacteriaceae, which poses a significant health risk.

Several plasmids carrying blaOXA-181 have been reported, including ColKP3, IncX3, IncT, and IncN1 replicons (72, 73). pHW8-CARBA-OXA-181 was found to be closely related to a ColKP3-type OXA-181 plasmid (CP061102.1) that we isolated in our previous research from an E. coli species in the stool of a pediatric patient with diarrhea from the same western region of Ghana. Although their phenotypic AMR profiles differ, it is speculated that the OXA-181 gene has been transmitted to other bacterial species. It has been reported that the conjugative transfer regions of self-transmissible MGEs typically comprise oriT, relaxase gene, T4CP, and T4SS (74). Consequently, the failure of plasmid pHW8-CARBA-OXA-181 to achieve conjugation may be attributed to the absence of a complete conjugation system. Nonetheless, the transfer of the blaOXA-181 gene through IS26-mediated co-integration with other plasmids is still possible. These findings highlight the need for future surveillance in this region from a One Health perspective, especially in animals. This is because the prevalence of blaOXA-181-producing Enterobacteriaceae has been reported in companion animals globally (75–77), yet there are no reports of such prevalence in Ghana, highlighting a potential gap in research or data collection in the region. We recommend that strategic educational policies should be developed and made readily accessible to communities, healthcare facilities, and food production sectors, providing timely and consolidated information on AMR and antimicrobial use. Furthermore, the hospital facilities should ensure proper sewage treatment to prevent indiscriminate spillage into neighboring communities. This information is essential for mitigating the adverse effects of AMR on human and animal health. It should also be recognized that environmental and food systems serve as vectors for the transmission of resistant pathogens. Moreover, continuous research involving clinical samples, animals, and environmental samples is necessary to monitor the spread of ARB and ARGs. ISEcp1 was found immediately upstream of blaOXA-181 on pHW8-CARBA-OXA-181 and CP061102.1, consistent with findings reported by Potron et al. and other β-lactamase resistance genes, such as blaCTX-M, blaCMY, and blaACC (78–81). ISEcp1 is likely involved in the expression of blaOXA-181 and serves as an efficient genetic vehicle for spreading clinically significant extended-spectrum β-lactamases (ESBLs), such as plasmid-encoded cephalosporinases and ESBLs (82); however, it was not found on plasmid CP061102.1. Reports indicate that ereA is located downstream of blaOXA-181 (83), as identified in CP061102.1; however, it may not have been annotated at the downstream region of blaOXA-181 on pHW8-CARBA-OXA-181 (Fig. 6). The ereA gene encodes erythromycin esterase type 1. Mobile genetic elements like IS26, ISEcp1, and IS2 are crucial for forming and propagating multi-resistant regions. IS26 often carries antibiotic resistance genes and facilitates their spread through replicative transposition. It is known to mediate the formation of cointegrates between two DNA molecules, with the donor molecule containing IS26 (84). pHW8-CARBA-OXA-181, in addition to blaOXA-181, also carried blaCTX-M-15 and qnrS1, which raises significant concerns about the risk of multidrug-resistant infections, complicating treatment strategies. Moreover, their resistance mechanisms may interact synergistically, reducing the effectiveness of these antibiotics and creating obstacles for successful patient outcomes.

MATERIALS AND METHODS

Sample collection site and bacterial isolation

In June 2023, a volume of 2,000 mL of wastewater was collected from the Effia Nkwanta Regional Hospital, located in Takoradi, Ghana. The wastewater underwent vigorous shaking, after which a ten-fold serial dilution was performed, and 100 µL was subsequently inoculated onto CHROagar mSuper CARBA agar plates. (Kanto Chemical Co., INC. Tokyo, Japan) and incubated at 37°C overnight. Subsequently, five to eight morphologically distinct colonies from each plate were passaged onto fresh agar plates and preserved in skim milk (Morinaga Milk, Tokyo, Japan) for subsequent analysis.

Species identification by 16S rRNA gene sequencing

Crude DNA was extracted from the isolates using CICA Geneus DNA Extraction Reagent (Kanto Chemical Co., Tokyo, Japan), as described earlier (85). We prepared a 10 µL PCR reaction mix consisting of 5 µL of 2× Emerald premix (Takara Bio Inc., Shiga, Japan), 0.5 µL of each forward 8UA (3 µM, 5′-AGAGTTTGATCMTGGCTCAG-3′) and reverse primer 1485B (3 µM, 5′-TACGGTTACCTTGTTACGAC-3′), 3 µL of nuclease-free water, and 1 µL of the DNA template. The polymerase chain reaction (PCR) process began with an initial denaturation at 98°C for 1 min, followed by 30 cycles of 98°C for 5 s, 57°C for 10 s, and 72°C for 1 min, concluding with a final extension at 72°C for 3 min. After amplification, the PCR products were purified using EXOSAP IT (Applied Biosystems, Foster City, CA, USA) and sequenced on a 3730xl DNA Analyzer with the BigDye Terminator v3.1 Cycle Sequencing Kit (Applied Biosystems). Identification of the sequences was conducted through National Center for Biotechnology Information (NCBI) BLAST searches utilizing a threshold identity of 100% and an e-value cutoff of 0.05, in accordance with the results obtained from sequencing.

Antimicrobial susceptibility testing and carbapenemase detection

The MICs of antibiotics were determined by broth micro-dilution using DP45 dry plates (Eiken Chemical Co., Tokyo, Japan) and MicroSCAN (Beckman Coulter, California, US), as described in the CLSI M100-S32 guideline (86). Isolates were further screened for carbapenemase production following the mCIM method, as outlined in the CLSI guidelines. The major carbapenemase genes, including those encoding VIM-, IMP-, NDM-, KPC-, and OXA-48-like carbapenemases, were screened (22).

Conjugation assays

The transferability of the blaNDM-1 and blaOXA-181 genes was assessed using the agar mating conjugal method, following a modified protocol previously described (32, 87). The sodium azide-resistant E. coli strain J53 served as the recipient strain. The 1 mL of recipient and 1 mL of donor strains (HW7-CARBA and HW8CARBA) were mixed in a 1:1 ratio, and the bacterial suspension or mixture was centrifuged at 10,000 × g for 3 min. Afterward, 1,800 μL of the supernatant was discarded, and the remaining 200 μL of each mix was vortexed and inoculated onto tryptone soy agar plates (Oxoid Ltd, Basingstoke, UK). The plates were incubated at 37°C overnight, and the bacterial cells were collected into 1 mL of 0.9% sterile physiological saline after the incubation to prepare a 10-fold serial dilution. The dilutions were spread onto bromothymol blue lactose agar plates (Eiken Chemical Co.) supplemented with 2 μg/mL meropenem and 100 μg/mL sodium azide to isolate the transconjugants (Tc-NDM-1) (87). The 100 μg/mL sodium azide was used as a selection criterion for the recipients (87). The presence of the blaNDM-1-containing plasmid was verified using PCR for carbapenemase genes and species identification.

Genome sequencing and analysis

Genomic DNA was extracted using the Magattract HMW DNA kit (Qiagen, Hildon, Germany) following the manufacturer’s guidelines. For short-read sequencing, libraries were constructed with the Illumina DNA prep method, utilizing the IDT for Illumina DNA/RNA UD Indexes, and sequenced on the Illumina Miniseq (Illumina Inc, San Diego, USA), resulting in reads of 150 bp in length (88). The quality of the short reads was evaluated using FastQC v0.11.9 (https://github.com/s-andrews/FastQC, accessed on 20 July 2024) (88). Reads were subsequently trimmed and filtered using fastp v0.23.1 (https://doi.org/10.1093/bioinformatics/bty560, accessed on 20 July 2024) (88). For long-read sequencing, libraries were prepared according to the manufacturer’s instructions using the native barcoding and ligation sequencing kits EXP-NB104 and SQK-LSK114 (Oxford Nanopore Technologies) (88). The libraries were then loaded onto MinION flow cells (R10.4.1), and sequencing was performed on the MinION Mk 1B (Oxford Nanopore Technologies) (88). The barcoded Fast5 reads generated were basecalled using Guppy v1.1.4. (https://community.nanoporetech.com/protocols/Guppy-protocol/ [accessed on 15 September 2024]) (88). Demultiplexing of reads and adapter sequence trimming were performed using Porechop v0.2.4 (89). Long reads with low quality (MinION Q < 10) and long reads ≤1,000 bp were filtered out with filtlong (https://github.com/rrwick/Filtlong [accessed on 15 September 2024]). Hybrid assembly of long read and short reads was done with Unicycler v0.4.8 (90). Identification of isolates was confirmed by whole-genome sequencing with Genome Taxonomy Database Toolkit (GTDB-Tk-v1.7.0) (91). Genomes were uploaded into the RAST online server for annotation (92). Assembled genomes were screened for acquired ARGs, STs, and replicon types through the web-based center for genomic epidemiology databases, ResFinder v4.7.2 (93), MLST (94), and PlasmidFinder (95). oriTfinder (96) was used to identify the origin of transfers in the plasmids that harbored blaNDM-1 and blaOXA-181. Comprehensive visual comparison of the plasmid sequences was performed using the BLAST Ring Image Generator (BRIG) v.0.98 (97). ARGs were also identified through the web-based database using the resistance gene identifier (RGI) (98). Virulence factors, ARGs, and resistant genes for heavy metals were identified using AMRfinderPlus v4.0.19 (99). Genetic context and comparison of the identified blaNDM-1 and blaOXA-181 gene structures were done using Easy Fig v.2.2.2 (100).

Phylogenetic analysis

To investigate the strains within a global context, a maximum-likelihood phylogenetic tree was constructed using a total of 34 C. portucalensis strains from the NCBI GenBank database (accessed on 17 June 2025), with assembly levels classified as scaffold, chromosome, or complete (Table S1) (18), including our study strains (HW7-CARBA and HW8-CARBA). Additionally, the phylogeny of pHW7-CARBA-NDM-1 and pHW8-CARBA-OXA-181 was evaluated, along with their respective 13 blaNDM-1 and blaOXA-181 plasmids, which exhibit high homology (percentage identity >99%). The plasmids were analyzed using NCBI BLASTn (accessed on 25 June 2025) with default settings, and selections were made from the first list of results, with a preference for plasmids derived from C. portucalensis and also isolated from Ghana or Africa. The raw reads were assembled using Unicycler v0.4.8 (90), and the genomes were annotated with Prokka v1.13 (101). Pangenome analysis was conducted utilizing Roary v3:12.0 (102). The plasmid phylogeny was based on core genes, and the resultant core-genome alignment file from Roary was utilized in Iqtree v2.2.0.3 to generate a phylogenetic tree with 1,000 bootstrapping replicates (103). The visualization and annotation of the trees were executed using ITOL v7 (https://itol.embl.de/ [accessed on 20 June 2025]), as previously described (104). The list of C. portucalensis genomes, blaOXA-181, and blaNDM-1 plasmid sequences is summarized in Tables S1 to S3, respectively.

Conclusion

This study represents the first instance of the identification of NDM-1- and OXA-181-producing C. portucalensis from HWW in Ghana. The resistant genes blaNDM-1 and blaOXA-181 were found to be associated with IncX3-type and ColKP3-type plasmids, respectively, suggesting the potential for horizontal transfer and further dissemination of these resistance genes among Enterobacteriaceae and other sources. Consequently, it is crucial to maintain continuous monitoring and ongoing attention to the detection of the difficult-to-identify C. portucalensis carrying blaNDM-1, blaOXA-181, and other resistance genes.

ACKNOWLEDGMENTS

We appreciate the support of the staff at the Effia Nkwanta hospital, Takoradi, Ghana.

This work was supported by AMED project numbers JP24wm0125007 and JP24wm0225022 and the Kajima Foundation’s Support Program for International Joint Research Activities.

Conceptualization, R.S.; data curation, M.S. and R.S.; formal analysis, F.O.A., J.S.A., and E.D.; funding acquisition, M.Y., M.S., Y.H., T.S., T.I., A.A., and R.S.; investigation, F.O.A., Y.O., and M.S.; methodology, F.O.A. and Y.O.; project administration, T.S., A.A., and R.S.; resources, A.A.; supervision, R.S.; writing – original draft, F.O.A. and R.S.; writing – review & editing, F.O.A, Y.O., J.S.A., E.D., M.Y., M.S., Y.H., T.S., T.I., A.A., and R.S. All authors read and approved the final manuscript.

Contributor Information

Ryoichi Saito, Email: r-saito.mi@tmd.ac.jp.

Satoshi Ishii, University of Minnesota Twin Cities, St. Paul, Minnesota, USA.

DATA AVAILABILITY

The data sets presented in this study can be found in the NCBI BioProject database under accession number PRJNA473419. The BioSample accession numbers of HW7-CARBA and HW8-CARBA are SAMN54532435 (JBVFOY000000000) and SAMN50771552 (JBQSUO000000000), respectively.

SUPPLEMENTAL MATERIAL

The following material is available online at https://doi.org/10.1128/aem.02108-25.

Fig. S1. aem.02108-25-s0001.docx.

PCR confirmation of blaNDM-1 in eight selected transconjugants.

aem.02108-25-s0001.docx (822.7KB, docx)
DOI: 10.1128/aem.02108-25.SuF1
Supplemental tables. aem.02108-25-s0002.xlsx.

Tables S1 to S9.

aem.02108-25-s0002.xlsx (106.1KB, xlsx)
DOI: 10.1128/aem.02108-25.SuF2

ASM does not own the copyrights to Supplemental Material that may be linked to, or accessed through, an article. The authors have granted ASM a non-exclusive, world-wide license to publish the Supplemental Material files. Please contact the corresponding author directly for reuse.

REFERENCES

  • 1. Abasse OG, Cissé H, Boukaré K, Sampo E, Bouda R, Stéphane KD, Savadogo A. 2020. Microbes and infectious diseases. doi: 10.21608/mid.2021.72261.1143 [DOI]
  • 2. Murray CJL, Ikuta KS, Sharara F, Swetschinski L, Robles Aguilar G, Gray A, Han C, Bisignano C, Rao P, Wool E, et al. 2022. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. The Lancet 399:629–655. doi: 10.1016/S0140-6736(21)02724-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 3. O’Neill J. 2016. "Tackling drug-resistant infections globally: final report and recommendations." p 84 [Google Scholar]
  • 4. Essack SY. 2018. Environment: the neglected component of the One Health triad. Lancet Planet Health 2:e238–e239. doi: 10.1016/S2542-5196(18)30124-4 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 5. Resnik DB. 2018. The ethics of research with human subjects: protecting people, advancing science, promoting trust. Vol. 74. Springer. [Google Scholar]
  • 6. Noor ZZ, Rabiu Z, Sani M, Samad AFA, Kamaroddin M, Perez MF, Dib JR, Fatima H, Sinha R, Khare SK, Zakaria ZA. 2021. A review of bacterial antibiotic resistance genes and their removal strategies from wastewater. Curr Pollution Rep 7:494–509. doi: 10.1007/s40726-021-00198-0 [DOI] [Google Scholar]
  • 7. Verlicchi P, Galletti A, Petrovic M, Barceló D. 2010. Hospital effluents as a source of emerging pollutants: an overview of micropollutants and sustainable treatment options. J Hydrol (Amst) 389:416–428. doi: 10.1016/j.jhydrol.2010.06.005 [DOI] [Google Scholar]
  • 8. Khalid S, Shahid M, Bibi I, Sarwar T, Shah AH, Niazi NK, Natasha . 2018. A review of environmental contamination and health risk assessment of wastewater use for crop irrigation with a focus on low and high-income countries. Int J Environ Res Public Health 15:895. doi: 10.3390/ijerph15050895 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9. Khan MT, Shah IA, Ihsanullah I, Naushad M, Ali S, Shah SHA, Mohammad AW. 2021. Hospital wastewater as a source of environmental contamination: an overview of management practices, environmental risks, and treatment processes. J Water Process Eng 41:101990. doi: 10.1016/j.jwpe.2021.101990 [DOI] [Google Scholar]
  • 10. Tariq A, Mushtaq A. 2023. Untreated wastewater reasons and causes: a review of most affected areas and cities. Int J Chem Biochem Sci 23:121–143. [Google Scholar]
  • 11. Hounmanou YMG, Mdegela RH, Dougnon TV, Mhongole OJ, Mayila ES, Malakalinga J, Makingi G, Dalsgaard A. 2016. Toxigenic Vibrio cholerae O1 in vegetables and fish raised in wastewater irrigated fields and stabilization ponds during a non-cholera outbreak period in Morogoro, Tanzania: an environmental health study. BMC Res Notes 9:466. doi: 10.1186/s13104-016-2283-0 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12. Munk P, Brinch C, Møller FD, Petersen TN, Hendriksen RS, Seyfarth AM, Kjeldgaard JS, Svendsen CA, van Bunnik B, Berglund F, Larsson DGJ, Koopmans M, Woolhouse M, Aarestrup FM, Global Sewage Surveillance Consortium . 2022. Genomic analysis of sewage from 101 countries reveals global landscape of antimicrobial resistance. Nat Commun 13:7251. doi: 10.1038/s41467-022-34312-7 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 13. Parida VK, Sikarwar D, Majumder A, Gupta AK. 2022. An assessment of hospital wastewater and biomedical waste generation, existing legislations, risk assessment, treatment processes, and scenario during COVID-19. J Environ Manage 308:114609. doi: 10.1016/j.jenvman.2022.114609 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 14. Hindiyeh M, Smollen G, Grossman Z, Ram D, Davidson Y, Mileguir F, Vax M, Ben David D, Tal I, Rahav G, Shamiss A, Mendelson E, Keller N. 2008. Rapid detection of blaKPC carbapenemase genes by real-time PCR. J Clin Microbiol 46:2879–2883. doi: 10.1128/JCM.00661-08 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15. Nordmann P, Poirel L, Toleman MA, Walsh TR. 2011. Does broad-spectrum beta-lactam resistance due to NDM-1 herald the end of the antibiotic era for treatment of infections caused by Gram-negative bacteria? J Antimicrob Chemother 66:689–692. doi: 10.1093/jac/dkq520 [DOI] [PubMed] [Google Scholar]
  • 16. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, Malamou-Lada E, Martinez-Martinez L, Navarro F, Nordmann P, Peixe L, Pournaras S, Rossolini GM, Tsakris A, Vatopoulos A, Cantón R. 2010. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect 16:112–122. doi: 10.1111/j.1469-0691.2009.03116.x [DOI] [PubMed] [Google Scholar]
  • 17. Durante-Mangoni E, Andini R, Zampino R. 2019. Management of carbapenem-resistant Enterobacteriaceae infections. Clin Microbiol Infect 25:943–950. doi: 10.1016/j.cmi.2019.04.013 [DOI] [PubMed] [Google Scholar]
  • 18. Yong D, Toleman MA, Giske CG, Cho HS, Sundman K, Lee K, Walsh TR. 2009. Characterization of a new metallo-beta-lactamase gene, bla(NDM-1), and a novel erythromycin esterase gene carried on a unique genetic structure in Klebsiella pneumoniae sequence type 14 from India. Antimicrob Agents Chemother 53:5046–5054. doi: 10.1128/AAC.00774-09 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 19. Poirel L, Revathi G, Bernabeu S, Nordmann P. 2011. Detection of NDM1producing Klebsiella pneumoniae in Kenya. Antimicrob Agents Chemother 55:934–936. doi: 10.1128/AAC.01247-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 20. Struelens MJ, Monnet DL, Magiorakos AP, Santos O’Connor F, Giesecke J, European NDM-1 Survey Participants . 2010. New Delhi metallo-beta-lactamase 1-producing Enterobacteriaceae: emergence and response in Europe. Euro Surveill 15:19716–19716. doi: 10.2807/ese.15.46.19716-en [DOI] [PubMed] [Google Scholar]
  • 21. Pillai DR, McGeer A, Low DE. 2011. New Delhi metallo-β-lactamase-1 in Enterobacteriaceae: emerging resistance. CMAJ 183:59–64. doi: 10.1503/cmaj.101487 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 22. Ayibieke A, Sato W, Mahazu S, Prah I, Addow-Thompson J, Ohashi M, Suzuki T, Iwanaga S, Ablordey A, Saito R. 2018. Molecular characterisation of the NDM-1-encoding plasmid p2189-NDM in an Escherichia coli ST410 clinical isolate from Ghana. PLoS One 13:e0209623. doi: 10.1371/journal.pone.0209623 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 23. Ofosu-Appiah F, Acquah EE, Mohammed J, Sakyi Addo C, Agbodzi B, Ofosu DA, Amissah NA. 2024. Klebsiella pneumoniae ST147 harboring bla NDM-1, multidrug resistance and hypervirulence plasmids. Microbiol Spectr 12:e03017–23. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24. Obeng-Nkrumah N, Labi A-K, Blankson H, Awuah-Mensah G, Oduro-Mensah D, Anum J, Teye J, Kwashie SD, Bako E, Ayeh-Kumi PF, Asmah R. 2018. Household cockroaches carry CTX-M-15, OXA-48 and NDM-1, and share beta-lactam resistance determinants with humans. bioRxiv. doi: 10.1101/357079 [DOI] [PMC free article] [PubMed]
  • 25. Naha S, Sands K, Mukherjee S, Saha B, Dutta S, Basu S. 2021. OXA-181-like carbapenemases in Klebsiella pneumoniae ST14, ST15, ST23, ST48, and ST231 from septicemic neonates: coexistence with NDM-5, resistome, transmissibility, and genome diversity. mSphere 6:e01156-20. doi: 10.1128/mSphere.01156-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 26. Poirel L, Ros A, Carricajo A, Berthelot P, Pozzetto B, Bernabeu S, Nordmann P. 2011. Extremely drug-resistant Citrobacter freundii isolate producing NDM-1 and other carbapenemases identified in a patient returning from India. Antimicrob Agents Chemother 55:447–448. doi: 10.1128/AAC.01305-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 27. Kalpoe JS, Al Naiemi N, Poirel L, Nordmann P. 2011. Detection of an Ambler class D OXA-48-type β-lactamase in a Klebsiella pneumoniae strain in The Netherlands. J Med Microbiol 60:677–678. doi: 10.1099/jmm.0.028308-0 [DOI] [PubMed] [Google Scholar]
  • 28. Castanheira M, Deshpande LM, Mathai D, Bell JM, Jones RN, Mendes RE. 2011. Early dissemination of NDM-1- and OXA-181-producing Enterobacteriaceae in Indian hospitals: report from the SENTRY Antimicrobial Surveillance Program, 2006-2007. Antimicrob Agents Chemother 55:1274–1278. doi: 10.1128/AAC.01497-10 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 29. Magobo RE, Ismail H, Lowe M, Strasheim W, Mogokotleng R, Perovic O, Kwenda S, Ismail A, Makua M, Bore A, Phayane R, Naidoo H, Dennis T, Ngobese M, Wijnant W, Govender NP, for Baby GERMS-SA1 . 2023. Outbreak of NDM-1–and OXA-181–producing Klebsiella pneumoniae bloodstream infections in a neonatal unit, South Africa. Emerg Infect Dis 29:1531–1539. doi: 10.3201/eid2908.230484 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 30. Uwaezuoke NS, Kieffer N, Iregbu KC, Nordmann P. 2017. First report of OXA-181 and NDM-1 from a clinical Klebsiella pneumoniae isolate from Nigeria. Int J Infect Dis 61:1–2. doi: 10.1016/j.ijid.2017.05.004 [DOI] [PubMed] [Google Scholar]
  • 31. Strydom KA, Chen L, Kock MM, Stoltz AC, Peirano G, Nobrega DB, Lowe M, Ehlers MM, Mbelle NM, Kreiswirth BN, Pitout JDD. 2020. Klebsiella pneumoniae ST307 with OXA-181: threat of a high-risk clone and promiscuous plasmid in a resource-constrained healthcare setting. J Antimicrob Chemother 75:896–902. doi: 10.1093/jac/dkz550 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 32. Prah I, Ayibieke A, Mahazu S, Sassa CT, Hayashi T, Yamaoka S, Suzuki T, Iwanaga S, Ablordey A, Saito R. 2021. Emergence of oxacillinase-181 carbapenemase-producing diarrheagenic Escherichia coli in Ghana. Emerg Microbes Infect 10:865–873. doi: 10.1080/22221751.2021.1920342 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33. Asare Yeboah EE, Agyepong N, Mbanga J, Amoako DG, Abia ALK, Ismail A, Owusu-Ofori A, Essack SY. 2024. Genomic characterization of multi drug resistant ESBL-producing Escherichia coli isolates from patients and patient environments in a teaching hospital in Ghana. BMC Microbiol 24:250. doi: 10.1186/s12866-024-03406-1 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 34. Labi A-K, Nielsen KL, Marvig RL, Bjerrum S, Enweronu-Laryea C, Bennedbæk M, Newman MJ, Ayibor PK, Andersen LP, Kurtzhals JAL. 2020. Oxacillinase-181 carbapenemase-producing Klebsiella pneumoniae in neonatal intensive care unit, Ghana, 2017–2019. Emerg Infect Dis 26:2235–2238. doi: 10.3201/eid2609.200562 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 35. Cao X, Xie H, Huang D, Zhou W, Liu Y, Shen H, Zhou K. 2021. Detection of a clinical carbapenem-resistant Citrobacter portucalensis strain and the dissemination of C. portucalensis in clinical settings. J Glob Antimicrob Resist 27:79–81. doi: 10.1016/j.jgar.2021.04.027 [DOI] [PubMed] [Google Scholar]
  • 36. Luo X, Yu L, Feng J, Zhang J, Zheng C, Hu D, Dai P, Xu M, Li P, Lin R, Mu K. 2022. Emergence of extensively drug-resistant ST170 Citrobacter portucalensis with plasmids pK218-KPC, pK218-NDM, and pK218-SHV from a tertiary hospital, China. Microbiol Spectr 10:e0251022. doi: 10.1128/spectrum.02510-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 37. Guo K, Zhao Z, Yang Y, Jiang X, Xu H, Tao F, Xu Y, Liu W. 2024. Emergence of an extensive drug resistant Citrobacter portucalensis clinical strain harboring blaSFO-1, blaKPC-2, and blaNDM-1. Infect Drug Resist:2273–2283. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 38. Zou H, Jia X, Liu H, Li S, Wu X, Huang S. 2020. Emergence of NDM-5-producing Escherichia coli in a teaching hospital in Chongqing, China: IncF-type plasmids may contribute to the prevalence of bla NDM–5. Front Microbiol 11:334. doi: 10.3389/fmicb.2020.00334 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 39. Jacoby GA, Griffin CM, Hooper DC. 2011. Citrobacter spp. as a source of qnrB alleles. Antimicrob Agents Chemother (Bethesda) 55:4979–4984. doi: 10.1128/AAC.05187-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 40. Choi S-H, Lee JE, Park SJ, Choi S-H, Lee S-O, Jeong J-Y, Kim M-N, Woo JH, Kim YS. 2008. Emergence of antibiotic resistance during therapy for infections caused by Enterobacteriaceae producing AmpC beta-lactamase: implications for antibiotic use. Antimicrob Agents Chemother 52:995–1000. doi: 10.1128/AAC.01083-07 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 41. Fakruddin M, Rahaman MM, Ahmed MM, Hoque MM. 2014. Antimicrobial resistance and virulence factors of Enterobacteriaceae isolated from food samples of Bangladesh. Int J Microbiol Immun Res 3:12–18. [Google Scholar]
  • 42. Okafor AC, Cabal Rosel A, Ogbo FC, Stöger A, Allerberger F, Ruppitsch W. 2022. draft genome sequence of Citrobacter cronae Awk (sequence type 880), associated with edible snails commercially available in Awka, Nigeria. Microbiol Resour Announc 11:e0063422. doi: 10.1128/mra.00634-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 43. O’Hara CM, Roman SB, Miller JM. 1995. Ability of commercial identification systems to identify newly recognized species of Citrobacter. J Clin Microbiol 33:242–245. doi: 10.1128/jcm.33.1.242-245.1995 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 44. Kolínská R, Španělová P, Dřevínek M, Hrabák J, Žemličková H. 2015. Species identification of strains belonging to genus Citrobacter using the biochemical method and MALDI-TOF mass spectrometry. Folia Microbiol 60:53–59. doi: 10.1007/s12223-014-0340-4 [DOI] [PubMed] [Google Scholar]
  • 45. Summers AO, Wireman J, Vimy MJ, Lorscheider FL, Marshall B, Levy SB, Bennett S, Billard L. 1993. Mercury released from dental “silver” fillings provokes an increase in mercury- and antibiotic-resistant bacteria in oral and intestinal floras of primates. Antimicrob Agents Chemother 37:825–834. doi: 10.1128/AAC.37.4.825 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 46. Lloyd NA, Janssen SE, Reinfelder JR, Barkay T. 2016. Co-selection of mercury and multiple antibiotic resistances in bacteria exposed to mercury in the Fundulus heteroclitus gut microbiome. Curr Microbiol 73:834–842. doi: 10.1007/s00284-016-1133-6 [DOI] [PubMed] [Google Scholar]
  • 47. Fang L, Li X, Li L, Li S, Liao X, Sun J, Liu Y. 2016. Co-spread of metal and antibiotic resistance within ST3-IncHI2 plasmids from E. coli isolates of food-producing animals. Sci Rep 6:25312. doi: 10.1038/srep25312 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 48. Lemire JA, Harrison JJ, Turner RJ. 2013. Antimicrobial activity of metals: mechanisms, molecular targets and applications. Nat Rev Microbiol 11:371–384. doi: 10.1038/nrmicro3028 [DOI] [PubMed] [Google Scholar]
  • 49. Yuan L, Li ZH, Zhang MQ, Shao W, Fan YY, Sheng GP. 2019. Mercury/silver resistance genes and their association with antibiotic resistance genes and microbial community in a municipal wastewater treatment plant. Sci Total Environ 657:1014–1022. doi: 10.1016/j.scitotenv.2018.12.088 [DOI] [PubMed] [Google Scholar]
  • 50. Ribeiro TG, Gonçalves BR, da Silva MS, Novais Â, Machado E, Carriço JA, Peixe L. 2017. Citrobacter portucalensis sp. nov., isolated from an aquatic sample. Int J Syst Evol Microbiol 67:3513–3517. doi: 10.1099/ijsem.0.002154 [DOI] [PubMed] [Google Scholar]
  • 51. Igbinosa EO, Rathje J, Habermann D, Brinks E, Cho G-S, Franz C. 2018. Draft genome sequence of multidrug-resistant strain Citrobacter portucalensis MBTC-1222, isolated from uziza (Piper guineense) leaves in Nigeria. Genome Announc 6:10–1128. doi: 10.1128/genomeA.00123-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 52. Hasan MS, Sultana M, Hossain MA. 2019. Complete genome arrangement revealed the emergence of a poultry origin superbug Citrobacter portucalensis strain NR-12. J Glob Antimicrob Resist 18:126–129. doi: 10.1016/j.jgar.2019.05.031 [DOI] [PubMed] [Google Scholar]
  • 53. Thomas SG, Abajorga M, Glover MA, Wengert PC, Parthasarathy A, Savka MA, Wadsworth CB, Shipman PA, Hudson AO. 2020. Aeromonas hydrophila RIT668 and Citrobacter portucalensis RIT669—potential zoonotic pathogens isolated from spotted turtles. Microorganisms 8:1805. doi: 10.3390/microorganisms8111805 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 54. Sellera FP, Fuentes-Castillo D, Fuga B, Goldberg DW, Kolesnikovas CKM, Lincopan N. 2023. New Delhi metallo-β-lactamase-1-producing Citrobacter portucalensis belonging to the novel ST264 causing fatal sepsis in a vulnerable migratory sea turtle. One Health 17:100590. doi: 10.1016/j.onehlt.2023.100590 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 55. Okafor AC, Rosel AC, Ogbo FC, Adetunji CO, Imarhiagbe O, Gamp L, Stöger A, Allerberger F, Ruppitsch W. 2024. Antibiotic resistance hotspot: comparative genomics reveals multiple strains of multidrug-resistant Citrobacter portucalensis in edible snails. Int J Mol Sci 25:9889. doi: 10.3390/ijms25189889 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 56. Liu Y, Feng Y, Wu W, Xie Y, Wang X, Zhang X, Chen X, Zong Z. 2015. First report of OXA-181-producing Escherichia coli in China and characterization of the isolate using whole-genome sequencing. Antimicrob Agents Chemother 59:5022–5025. doi: 10.1128/AAC.00442-15 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 57. Cho SY, Huh HJ, Baek JY, Chung NY, Ryu JG, Ki C-S, Chung DR, Lee NY, Song J-H. 2015. Klebsiella pneumoniae co-producing NDM-5 and OXA-181 carbapenemases, South Korea. Emerg Infect Dis 21:1088–1089. doi: 10.3201/eid2106.150048 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 58. Nahid F, Zahra R, Sandegren L. 2017. A blaOXA-181-harbouring multi-resistant ST147 Klebsiella pneumoniae isolate from Pakistan that represent an intermediate stage towards pan-drug resistance. PLoS One 12:e0189438. doi: 10.1371/journal.pone.0189438 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 59. Poirel L, Héritier C, Tolün V, Nordmann P. 2004. Emergence of oxacillinase-mediated resistance to imipenem in Klebsiella pneumoniae. Antimicrob Agents Chemother 48:15–22. doi: 10.1128/AAC.48.1.15-22.2004 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 60. Poirel L, Castanheira M, Carrër A, Rodriguez CP, Jones RN, Smayevsky J, Nordmann P. 2011. OXA-163, an OXA-48-related class D β-lactamase with extended activity toward expanded-spectrum cephalosporins. Antimicrob Agents Chemother 55:2546–2551. doi: 10.1128/AAC.00022-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 61. Sun L, Meng N, Wang H, Wang Z, Jiao X, Wang J. 2024. Occurrence and characteristics of blaOXA-181-carrying Klebsiella aerogenes from swine in China. J Glob Antimicrob Resist 38:35–41. doi: 10.1016/j.jgar.2024.04.009 [DOI] [PubMed] [Google Scholar]
  • 62. Poirel L, Potron A, Nordmann P. 2012. OXA-48-like carbapenemases: the phantom menace. Journal of Antimicrobial Chemotherapy 67:1597–1606. doi: 10.1093/jac/dks121 [DOI] [PubMed] [Google Scholar]
  • 63. Cuicapuza D, Alvarado L, Tocasca N, Aguilar D, Gómez-de-la-Torre JC, Salvatierra G, Tsukayama P, Tamariz J. 2023. First report of OXA-181-producing Enterobacterales isolates in Latin America. Microbiol Spectr 11:e0458422. doi: 10.1128/spectrum.04584-22 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 64. Antimicrobial Resistance (AMR) . Available from: https://www.healthdata.org/research-analysis/health-risks-issues/antimicrobial-resistance-amr. Retrieved 22 Dec 2025.
  • 65. Donkor ES, Odoom A, Osman A-H, Darkwah S, Kotey FCN. 2024. A systematic review on antimicrobial resistance in Ghana from a One Health perspective. Antibiotics (Basel) 13:662. doi: 10.3390/antibiotics13070662 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 66. Wu W, Feng Y, Tang G, Qiao F, McNally A, Zong Z. 2019. NDM metallo-β-lactamases and their bacterial producers in health care settings. Clin Microbiol Rev 32:10–1128. doi: 10.1128/CMR.00115-18 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 67. Ma Z, Zeng Z, Liu J, Liu C, Pan Y, Zhang Y, Li Y. 2021. Emergence of IncHI2 plasmid-harboring blaNDM-5 from porcine Escherichia coli isolates in Guangdong, China. Pathogens 10:954. doi: 10.3390/pathogens10080954 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 68. Dortet L, Girlich D, Virlouvet A-L, Poirel L, Nordmann P, Iorga BI, Naas T. 2017. Characterization of BRPMBL, the bleomycin resistance protein associated with the Carbapenemase NDM. Antimicrob Agents Chemother 61:e02413-16. doi: 10.1128/AAC.02413-16 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 69. Alattraqchi AG, Mohd Rani F, A Rahman NI, Ismail S, Cleary DW, Clarke SC, Yeo CC. 2021. Complete genome sequencing of Acinetobacter baumannii AC1633 and Acinetobacter nosocomialis AC1530 unveils a large multidrug-resistant plasmid encoding the NDM-1 and OXA-58 carbapenemases. mSphere 6:e01076-20. doi: 10.1128/mSphere.01076-20 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 70. Corrêa LL, Kraychete GB, Rezende AM, Campana EH, Lima-Morales D, Wink PL, Picão RC. 2021. NDM-1-encoding plasmid in Acinetobacter chengduensis isolated from coastal water. Infect Genet Evol 93:104926. doi: 10.1016/j.meegid.2021.104926 [DOI] [PubMed] [Google Scholar]
  • 71. Acman M, Wang R, van Dorp L, Shaw LP, Wang Q, Luhmann N, Yin Y, Sun S, Chen H, Wang H, Balloux F. 2022. Role of mobile genetic elements in the global dissemination of the carbapenem resistance gene blaNDM Nat Commun 13:1131. doi: 10.1038/s41467-022-28819-2 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 72. Pitout JDD, Peirano G, Kock MM, Strydom K-A, Matsumura Y. 2019. The global ascendency of OXA-48-type carbapenemases. Clin Microbiol Rev 33:10–1128. doi: 10.1128/CMR.00102-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 73. Villa L, Carattoli A, Nordmann P, Carta C, Poirel L. 2013. Complete sequence of the IncT-type plasmid pT-OXA-181 carrying the blaOXA-181 carbapenemase gene from Citrobacter freundii. Antimicrob Agents Chemother 57:1965–1967. doi: 10.1128/AAC.01297-12 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 74. Burrus V. 2017. Mechanisms of stabilization of integrative and conjugative elements. Curr Opin Microbiol 38:44–50. doi: 10.1016/j.mib.2017.03.014 [DOI] [PubMed] [Google Scholar]
  • 75. Doloy A, Verdet C, Gautier V, Decré D, Ronco E, Hammami A, Arlet G. 2006. Genetic environment of acquired bla ACC-1 β-lactamase gene in Enterobacteriaceae isolates. Antimicrob Agents Chemother (Bethesda) 50:4177–4181. doi: 10.1128/AAC.00619-06 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 76. Nigg A, Brilhante M, Dazio V, Clément M, Collaud A, Gobeli Brawand S, Willi B, Endimiani A, Schuller S, Perreten V. 2019. Shedding of OXA-181 carbapenemase-producing Escherichia coli from companion animals after hospitalisation in Switzerland: an outbreak in 2018. Euro Surveill 24:1900071. doi: 10.2807/1560-7917.ES.2019.24.39.1900071 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 77. Spahr Y, Nordmann P, Fernandez JE, Poirel L, Endimiani A, Perreten V. 2025. Genomic analyses of Escherichia coli ST410 harbouring the blaOXA-181 carbapenemase gene from companion animals and humans in Switzerland. J Appl Microbiol 136:lxaf181. doi: 10.1093/jambio/lxaf181 [DOI] [PubMed] [Google Scholar]
  • 78. Brilhante M, Menezes J, Belas A, Feudi C, Schwarz S, Pomba C, Perreten V. 2020. OXA-181-producing extraintestinal pathogenic Escherichia coli sequence type 410 isolated from a dog in Portugal. Antimicrob Agents Chemother 64:10–1128. doi: 10.1128/AAC.02298-19 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 79. Nakano R, Okamoto R, Nagano N, Inoue M. 2007. Resistance to gram-negative organisms due to high-level expression of plasmid-encoded ampC beta-lactamase blaCMY-4 promoted by insertion sequence ISEcp1. J Infect Chemother 13:18–23. doi: 10.1007/s10156-006-0483-6 [DOI] [PubMed] [Google Scholar]
  • 80. Poirel L, Decousser JW, Nordmann P. 2003. Insertion sequence IS Ecp1B IS involved in expression and mobilization of a bla CTX-M β-lactamase gene. Antimicrob Agents Chemother (Bethesda) 47:2938–2945. doi: 10.1128/AAC.47.9.2938-2945.2003 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 81. Poirel L, Lartigue MF, Decousser JW, Nordmann P. 2005. IS Ecp1B-mediated transposition of bla CTX-M in Escherichia coli. Antimicrob Agents Chemother (Bethesda) 49:447–450. doi: 10.1128/AAC.49.1.447-450.2005 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 82. Potron A, Nordmann P, Lafeuille E, Al Maskari Z, Al Rashdi F, Poirel L. 2011. Characterization of OXA-181, a carbapenem-hydrolyzing class D beta-lactamase from Klebsiella pneumoniae. Antimicrob Agents Chemother 55:4896–4899. doi: 10.1128/AAC.00481-11 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 83. Meunier D, Doumith M, Findlay J, Mustafa N, Mallard K, Anson J, Panagea S, Pike R, Wright L, Woodford N, Hopkins KL. 2016. Carbapenem resistance mediated by blaOXA-181 in Pseudomonas aeruginosa. J Antimicrob Chemother 71:2056–2057. doi: 10.1093/jac/dkw087 [DOI] [PubMed] [Google Scholar]
  • 84. Mollet B, Iida S, Arber W. 1985. Gene organization and target specificity of the prokaryotic mobile genetic element IS26. Molec Gen Genet 201:198–203. doi: 10.1007/BF00425660 [DOI] [PubMed] [Google Scholar]
  • 85. Mahazu S, Prah I, Ayibieke A, Sato W, Hayashi T, Suzuki T, Iwanaga S, Ablordey A, Saito R. 2021. Possible dissemination of Escherichia coli sequence type 410 closely related to B4/H24RxC in Ghana. Front Microbiol 12:770130. doi: 10.3389/fmicb.2021.770130 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 86. Clinical and Laboratory Standards Institute . 2020. Performance standards for antimicrobial susceptibility testing. In CLSI Document M100-S30, 30th ed. Clinical and Laboratory Standards Institute, Wayne, PA, USA. [Google Scholar]
  • 87. Prah I, Nukui Y, Yamaoka S, Saito R. 2022. Emergence of a high-risk Klebsiella michiganensis clone disseminating carbapenemase genes. Front Microbiol 13:880248. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 88. Ofosu Appiah F, Mahazu S, Prah I, Kawamura T, Ota Y, Nishikawa Y, Yoshida M, Suzuki M, Hoshino Y, Suzuki T, Ishino T, Ablordey A, Saito R. 2025. Emergence of carbapenem-resistant blaPOM-1 harboring Pseudomonas otitidis isolated from river water in Ghana. Antibiotics (Basel) 14:50. doi: 10.3390/antibiotics14010050 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 89. Suzuki M, Suzuki S, Matsui M, Hiraki Y, Kawano F, Shibayama K. 2014. A subclass B3 metallo-β-lactamase found in Pseudomonas alcaligenes. J Antimicrob Chemother 69:1430–1432. doi: 10.1093/jac/dkt498 [DOI] [PubMed] [Google Scholar]
  • 90. Wick RR, Judd LM, Gorrie CL, Holt KE. 2017. Unicycler: resolving bacterial genome assemblies from short and long sequencing reads. PLoS Comput Biol 13:e1005595. doi: 10.1371/journal.pcbi.1005595 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 91. Chaumeil P-A, Mussig AJ, Hugenholtz P, Parks DH. 2020. GTDB-Tk: a toolkit to classify genomes with the Genome Taxonomy Database. Bioinformatics 36:1925–1927. doi: 10.1093/bioinformatics/btz848 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 92. Aziz RK, Bartels D, Best AA, DeJongh M, Disz T, Edwards RA, Formsma K, Gerdes S, Glass EM, Kubal M, et al. 2008. The RAST Server: rapid annotations using subsystems technology. BMC Genomics 9:75. doi: 10.1186/1471-2164-9-75 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 93. Bortolaia V, Kaas RS, Ruppe E, Roberts MC, Schwarz S, Cattoir V, Philippon A, Allesoe RL, Rebelo AR, Florensa AF, et al. 2020. ResFinder 4.0 for predictions of phenotypes from genotypes. J Antimicrob Chemother 75:3491–3500. doi: 10.1093/jac/dkaa345 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 94. Platt S, Pichon B, George R, Green J. 2006. A bioinformatics pipeline for high-throughput microbial multilocus sequence typing (MLST) analyses. Clin Microbiol Infect 12:1144–1146. doi: 10.1111/j.1469-0691.2006.01541.x [DOI] [PubMed] [Google Scholar]
  • 95. Carattoli A, Hasman H. 2020. PlasmidFinder and In Silico pMLST: identification and typing of plasmid replicons in whole-genome sequencing (WGS). In de la Cruz F (ed), Horizontal Gene Transfer. Methods in Molecular Biology. Vol. 2075. Humana, New York, NY. [DOI] [PubMed] [Google Scholar]
  • 96. Li X, Xie Y, Liu M, Tai C, Sun J, Deng Z, Ou H-Y. 2018. oriTfinder: a web-based tool for the identification of origin of transfers in DNA sequences of bacterial mobile genetic elements. Nucleic Acids Res 46:W229–W234. doi: 10.1093/nar/gky352 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 97. Alikhan N-F, Petty NK, Ben Zakour NL, Beatson SA. 2011. BLAST Ring Image Generator (BRIG): simple prokaryote genome comparisons. BMC Genomics 12:402. doi: 10.1186/1471-2164-12-402 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 98. Alcock BP, Raphenya AR, Lau TTY, Tsang KK, Bouchard M, Edalatmand A, Huynh W, Nguyen A-LV, Cheng AA, Liu S, et al. 2020. CARD 2020: antibiotic resistome surveillance with the comprehensive antibiotic resistance database. Nucleic Acids Res 48:D517–D525. doi: 10.1093/nar/gkz935 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 99. Feldgarden M, Brover V, Fedorov B, Haft DH, Prasad AB, Klimke W. 2022. Curation of the AMRFinderPlus databases: applications, functionality and impact. Microb Genom 8:000832. doi: 10.1099/mgen.0.000832 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 100. Sullivan MJ, Petty NK, Beatson SA. 2011. Easyfig: a genome comparison visualizer. Bioinformatics 27:1009–1010. doi: 10.1093/bioinformatics/btr039 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 101. Seemann T. 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30:2068–2069. doi: 10.1093/bioinformatics/btu153 [DOI] [PubMed] [Google Scholar]
  • 102. Page AJ, Cummins CA, Hunt M, Wong VK, Reuter S, Holden MTG, Fookes M, Falush D, Keane JA, Parkhill J. 2015. Roary: rapid large-scale prokaryote pan genome analysis. Bioinformatics 31:3691–3693. doi: 10.1093/bioinformatics/btv421 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 103. Nguyen L-T, Schmidt HA, von Haeseler A, Minh BQ. 2015. IQ-TREE: a fast and effective stochastic algorithm for estimating maximum-likelihood phylogenies. Mol Biol Evol 32:268–274. doi: 10.1093/molbev/msu300 [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 104. Letunic I, Bork P. 2019. Interactive Tree Of Life (iTOL) v4: recent updates and new developments. Nucleic Acids Res 47:W256–W259. doi: 10.1093/nar/gkz239 [DOI] [PMC free article] [PubMed] [Google Scholar]

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Fig. S1. aem.02108-25-s0001.docx.

PCR confirmation of blaNDM-1 in eight selected transconjugants.

aem.02108-25-s0001.docx (822.7KB, docx)
DOI: 10.1128/aem.02108-25.SuF1
Supplemental tables. aem.02108-25-s0002.xlsx.

Tables S1 to S9.

aem.02108-25-s0002.xlsx (106.1KB, xlsx)
DOI: 10.1128/aem.02108-25.SuF2

Data Availability Statement

The data sets presented in this study can be found in the NCBI BioProject database under accession number PRJNA473419. The BioSample accession numbers of HW7-CARBA and HW8-CARBA are SAMN54532435 (JBVFOY000000000) and SAMN50771552 (JBQSUO000000000), respectively.


Articles from Applied and Environmental Microbiology are provided here courtesy of American Society for Microbiology (ASM)

RESOURCES